Efficacy and Safety of Selumetinib in Adults With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas
Clinical trial NCT04924608 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04924608
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-19
- Primary completion
- 2024-08-05
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.